Form 8-K - Current report:
SEC Accession No. 0001104659-22-112677
Filing Date
2022-10-31
Accepted
2022-10-31 07:00:31
Documents
13
Period of Report
2022-10-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229125d1_8k.htm   iXBRL 8-K 42835
  Complete submission text file 0001104659-22-112677.txt   270510

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vcka-20221028.xsd EX-101.SCH 3895
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vcka-20221028_def.xml EX-101.DEF 27104
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcka-20221028_lab.xml EX-101.LAB 37162
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcka-20221028_pre.xml EX-101.PRE 25722
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2229125d1_8k_htm.xml XML 6348
Mailing Address 85 BROAD STREET, 29TH FLOOR NEW YORK NY 10004
Business Address 85 BROAD STREET, 29TH FLOOR NEW YORK NY 10004 (646) 974-8301
Vickers Vantage Corp. I (Filer) CIK: 0001820190 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39852 | Film No.: 221343773
SIC: 2836 Biological Products, (No Diagnostic Substances)